Related Articles
PD‑L1/PD‑1 blockade in breast cancer: The immunotherapy era (Review)
miR‑30a inhibits epithelial‑mesenchymal transition and metastasis in triple‑negative breast cancer by targeting ROR1
GROα overexpression drives cell migration and invasion in triple negative breast cancer cells
CSF1 is involved in breast cancer progression through inducing monocyte differentiation and homing
Upregulation of PD‑L1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300‑mediated NF‑κB signaling